While writing my new book, I came across the following...
Interpretation of the evidence for the efficacy and safety of statin therapy
Declaration of interests
…it has a staff policy of not taking personal payments from industry (with reimbursement sought only for the costs of travel and accommodation to attend scientific meetings).
@..@ is co-inventor of a genetic test for statin-related myopathy risk, but receives no income from it.
@..@ has received research grants from, and served as a consultant to, Merck and Pfizer.
@..@ has twice received travel and accommodation funding and honoraria from Merck.
@..@ receives compensation for serving on data monitoring committees for clinical trials (including of statins) funded by Abbvie, Actelion, Amgen, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck, Sanofi and Teva.
@..@ has received research grants for research on statins and polypill development from Bristol-Myers Squibb and BUPA.
@..@ declares that George Health Enterprises, the social enterprise arm of the George Institute, has received investment to develop combination products containing statin, aspirin, and blood-pressure-lowering drugs.
= = =
It's bloody elementary, my Dear Watson ◎